Cone snail venom peptide could enable injectable non-opioid pain relief
An international research team led by the Medical University of Vienna has investigated a new peptide derived from cone snail venom that significantly reduced inflammation-induced pain in an animal model. Crucially, its effect takes hold immediately after subcutaneous injection, whereas previously known cone snail peptides must be administered directly into the cerebrospinal fluid.
The health section covers stories about medical progress, recovery, and wellbeing. We look for genuine advances: new therapies clearing regulatory hurdles, diseases being eradicated in specific regions, communities improving public health outcomes through evidence-based programs. Celebrity wellness trends and supplement marketing do not make the cut.
Fampridine boosts nerve signals to make it easier to walk, with up to 5,000 eligible.
Joe Marler tells BBC Sport's Alex Fletcher about the benefits of cycling.
Researchers are applying evolutionary theory to cancer by changing treatments before tumors have time to develop resista…
HHS Joins the Genesis Mission to End America’s Chronic Disease Epidemic HHS.gov